Brand Drug Enterprises Holding Group "drug cooperation"

For the long-term development of Chinese medicine industry, the crisis of raw materials or may become an opportunity, not only make the pharmaceutical enterprises aware of the importance of raw materials, but also can completely solve the long-standing problems of the industry's provenance, production patterns, standardization of medicinal materials, trade information transparency and so on a series of issues, the memorandum of The price of raw materials for Chinese herbal medicine, the industry people think may become an opportunity. July 2, held in Qingdao, the third Chinese brand Pharmaceutical Enterprise Salon (hereinafter referred to as APS), Donga Gelatin, Yunnan white powder, tasly and other domestic brands of Chinese Medicine Enterprises signed a memorandum of cooperation, said will be "planting base of Chinese herbal medicine and provenance base construction", "Chinese herbal medicine planting technology research and development,　　Training and the cultivation of information input, "" The raw materials of traditional Chinese medicine reserves and trading platform for the construction of "self-care, scientific and health market atmosphere to create" and other aspects of cooperation. Crazy Chinese Herbal medicine since the second half of 2009, the raw materials become a "dark horse." According to the monitoring data released by Chinese Herbal Medicine Information Center of China Association of Chinese Medicines, in 2010, more than 80% medicinal materials rose in the National 537 medicinal herbs, with an average increase of 109%, and the rise of individual medicinal herbs as high as 400%. Unlike other agricultural and sideline products, the price of traditional Chinese medicine has not seen　　Up to now, has ushered in the seventh time tide.　　In this respect, Yunnan White Medicine chairman Wang pointed out that last year, the raw material procurement cost of white powder increased by 40 million yuan, Donga donkey-Hide gelatin general Manager Qin also said Donga Donkey-hide the main raw materials of the 3-4-fold, which is the main raw material donkey skin price has reached the highest level of history. But because the pharmaceutical industry is related to the livelihood of the nation, the government for the basic drug catalogue products strict price, resulting in this part of the product no price increase space.　　In addition, human costs, financing costs rise and so on are complications, constitute the traditional Chinese medicine and herbal pieces of the cost of the test. According to Fang, president of the Chinese Association of Chinese Medicine, according to the State Council leadership relevant instructions, the National Development and Reform Commission, Ministry of Commerce, the State administration of Chinese Medicine, China Association of Chinese Medicines jointly organized research group, is the National herbal medicine market and price situation to carry out research, clear the recent price abnormal rise　　Research and propose policy measures to stabilize the price of Chinese herbal medicines.　　Raw material base of the competition for raw materials prices of traditional Chinese medicine companies realize the importance of controlling the "first workshop", many enterprises under construction or pre-built raw materials base, in order to control the upstream resources. But in the case of the self-built raw material base of the horse race, several companies involved in the APS apparently disagree. tasly Group Chairman Shing pointed out that the planting link belongs to the agricultural category, while the land is the fundamental to the survival of farmers, if the pharmaceutical companies to plant drugs, not only may arouse the farmers ' negative emotions, but also the distribution of resources unreasonable performance. The rational mode is that the pharmaceutical enterprises become a designer, so that farmers to plant good medicine, which is a research and development of provenances, varieties cultivation, planting technology training, pest control and so onSystems engineering, and the current problem is that the pharmaceutical enterprises in this area of relatively insufficient investment, especially the lack of science and technology support, resulting in the standard of medicinal herbs, the normative standards can not be in line with the world standards. Yunnan White Powder chairman Wang that, because of its production involved in a lot of medicinal materials, enterprises can not take everywhere drop of the extension of the base construction, only likely to choose such as heavy building, 37 of such major varieties for the construction of self-built base.　　And because some wild Chinese herbal medicines are endangered, relative to the construction of Chinese herbal medicine base, the construction of provenance base is more urgent. Circulation link Shengar In addition to the production field of the debate, the current APS another focus on the issue of circulation. Qin, the APS rotating president, told reporters: "and other agricultural products exist in the circulation of shackles, such as the link is too long, information opaque, lack of reserves and early warning system, the problem of the spread of transactions also exist in the circulation of medicinal materials." "In this respect, SIG Pharmaceutical general manager Xu Dongjin said, drug buyers, distributors, distributors, such as multiple links lead to the price of Chinese medicine Shengar, the chain too long to the hot money speculation provides space."　　At present, the industry lacks a brand of large-scale medicinal herbs market, in this quality assurance market, can carry out from the origin to the direct docking of manufacturers, and Kang Mei is in the beginning of the relevant market integration. In addition, Qin said, because the information asymmetry brought about the price instability and drug shortage and so on to establish an information-based trading platform, on this platform, you can let enterprises and farmers understand the supply and demand information and determine the future price trend.　　And when the time is ripe can also use the delay trade mechanism, reduce the warehousing cost, enable the enterprise to achieve low inventory of benign operation.　　Many participants at the same time pointed out that the lack of national reserve system for Chinese herbal medicine price fluctuations and speculation left a space for the long-term development of Chinese medicine industry, should establish the system as soon as possible. Brand pharmaceutical companies want to create a worry-free "drug storehouse" in the industry, in the context of national policy on drug prices continue to control, through the mode of innovation, product innovation to extend the pharmaceutical industry chain to avoid the risk of drug price reduction is the sustainable development of pharmaceutical enterprises the realistic choice.　　And this APS is seeking a possible direction cooperation for model innovation. "APS organization can be the first to try to cooperate, through the construction of raw materials base, and jointly build a reserve trading platform to effectively fundamentally ensure the safety of raw materials?" Sharon, Qin's proposal was widely accepted by the participants.　　According to the Ying of the production and circulation of Chinese herbal medicines, members said that this is not relying on one's own force can be changed, to tasly for example, although in the building of Traditional Chinese medicine standardization industry started earlier, but so far only completed a GMP certification of medicinal materials. After the salon, 7 companies will send representatives to set up a working group to conduct specific consultations on the details of the cooperation. It is reported that the first combination of raw materials base may be located in Gansu or Ningxia.